When you go to “COOKIES INCL. ALLOW US SERVICES” click, you agree to the storage of cookies on your device to improve website navigation, analyze site usage, and support our marketing efforts. For more information, see our Privacy statement.
Spherox is the only advanced therapy (ATMP) drug approved by EMA for the treatment of cartilage damage. It is a personalized cell therapy made from the patient's autologous cartilage tissue. The cells are isolated, multiplied and transplanted in the form of spheroids in order to fully integrate into the existing, healthy cartilage.
Active substance
Spheroids from human autologous matrix-associated chondrocytes
Dosage form
1 pre-filled syringe with isotonic saline solution and spheroids
To use further information on this page, you must be registered as a doctor with DocCheck. We would like to ask for your understanding that, in accordance with the provisions of the Austrian Medicines Act, certain detailed information is only available to medical personnel.
When you fill out this form, your data will be sent to Doccheck. This is only necessary to verify that they are a doctor.
